Credent Global Finance Ltd.
Credent Global Fin.
₹ 0.00
0.00 (0.00)%
NSE
BSE
Finance
Small-cap - With a market cap of ₹1.80 Cr.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Audited Results |
| 14 08 2021 | Quarterly Results |
| 28 10 2021 | Quarterly Results |
| 05 02 2022 | Quarterly Results & Increase in Authorised Capital |
| 31 03 2022 | Preferential Issue of shares Inter alia, to transact the following businesses: 1. To consider issue and allotment of Equity Shares at a price to be determined in accordance with the pricing formula prescribed under Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013 for cash and/or consideration other than cash on the preferential basis to the Non Promoters - Public Category; 2. To consider and approve the notice of the Postal Ballot and finalized the Calendar of Events. 3. To consider and Approve the appointment of scrutinizer in respect to conduct Postal Ballot process and scrutiny of Postal ballot voting along with E-Voting Results. 4. To Consider and discuss any other items as may be decided by the Board of Directors of the Company. |
| 23 05 2022 | Preferential Issue of shares & Audited Results |
| 10 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 03 02 2023 | Quarterly Results |
| 10 02 2023 | Interim Dividend |
| 27 03 2023 | Inter alia, , to transact the following business: 1. To consider & approve the raising of funds by way of right issue (?Right Issue?), in accordance with the Companies Act, 2013 and the rules made there under, Securities Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws. 2. To consider and approve the increase in Authorized Share Capital of the Company pursuant to Right Issue. 3. To consider any other matter with the permission of the Chair as the Board may think fit or which is incidental and ancillary to the business of the Company |
| 29 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 06 03 2025 | Inter alia, to consider and approve:- (1) Fund raising by way of issue of Secured Non-Convertible Debentures on private placement basis in one or more series / tranches, as may be decided by the Board of Directors/ Committee from time to time. |
| 30 05 2025 | Audited Results |
| 13 08 2025 | Quarterly Results |
| 10 10 2025 | Increase in Authorised Capital & Inter alia, to transact the following business: 1. To consider and approve the proposal of raising of funds by way of issuance equity shares through permissible modes, including but not limited to a public issue, preferential allotment, private placement, including one or more qualified institutional placement (?QIP?) or through any other permissible mode and/or combination thereof as may be considered appropriate under applicable law, subject to statutory/regulatory approvals as may be required and the approval of Shareholders of the Company. 2. To consider and approve the increase in Authorized Share Capital of the Company. 3. To consider any other matter with the permission of the Chair as the Board may think fit or which is incidental and ancillary to the business of the Company. |
| 14 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
